ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding ClearPoint Neuro, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 81 | 86 | +5 |
| Shares | 7.54M | 7.06M | −482.4K (−6.4%) |
| Value | $51.3M | $38.0M | −$13.2M (−25.8%) |
New holders (22)
Institutions that held ClearPoint Neuro, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 101,773 | $548.6K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 79,650 | $429.3K | 0.02% |
| Cubist Systematic Strategies, LLC | 77,750 | $419.1K | 0.01% |
| Rinkey Investments | 57,015 | $307.3K | 0.11% |
| Qube Research & Technologies Ltd | 51,789 | $279.1K | 0.00% |
| Trexquant Investment LP | 43,882 | $236.5K | 0.00% |
| Centiva Capital, LP | 39,199 | $211.3K | 0.01% |
| Point72 Asia (Singapore) Pte. Ltd. | 32,424 | $174.8K | 0.04% |
| Schonfeld Strategic Advisors LLC | 27,234 | $146.8K | 0.00% |
| HRT Financial LP | 27,062 | $145.0K | 0.00% |
| Corton Capital Inc. | 24,494 | $132.0K | 0.07% |
| Paloma Partners Management Co | 22,500 | $121.3K | 0.01% |
| Virtu Financial LLC | 19,572 | $105.0K | 0.01% |
| Sherbrooke Park Advisers LLC | 17,181 | $92.6K | 0.02% |
| Jump Financial, LLC | 16,946 | $91.3K | 0.00% |
| Brevan Howard Capital Management LP | 13,218 | $71.2K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 11,389 | $61.4K | 0.00% |
| Point72 (DIFC) Ltd | 6,010 | $32.4K | 0.00% |
| Catalyst Funds Management Pty Ltd | 4,400 | $23.7K | 0.01% |
| Macquarie Group Ltd | 1,125 | $6.06K | 0.00% |
| Advisor Group Holdings, Inc. | 725 | $3.91K | 0.00% |
| CWM, LLC | 13 | $0 | 0.00% |
Sold out (17)
Institutions that held ClearPoint Neuro, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| AWM Investment Company, Inc. | 131,431 | $893.7K |
| Bank of New York Mellon Corp | 55,689 | $378.7K |
| Nuveen Asset Management, LLC | 33,564 | $228.2K |
| Royce & Associates LP | 29,205 | $198.6K |
| UBS Asset Management Americas Inc | 28,261 | $192.2K |
| Deutsche Bank AG | 19,076 | $129.7K |
| Calamos Advisors LLC | 16,586 | $112.8K |
| MetLife Investment Management | 12,254 | $83.3K |
| American International Group, Inc. | 11,298 | $76.8K |
| Manufacturers Life Insurance Company, The | 10,388 | $70.6K |
| Invesco Ltd. | 10,179 | $69.2K |
| California State Teachers Retirement System | 2,305 | $15.7K |
| Legal & General Group Plc | 2,261 | $15.4K |
| Ameritas Investment Partners, Inc. | 1,893 | $12.9K |
| Metropolitan Life Insurance Co | 1,270 | $8.64K |
| Amalgamated Bank | 773 | $5.00K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 4 | $27 |